These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27811370)

  • 21. Increased argonaute 2 expression in gliomas and its association with tumor progression and poor prognosis.
    Feng B; Hu P; Lu SJ; Chen JB; Ge RL
    Asian Pac J Cancer Prev; 2014; 15(9):4079-83. PubMed ID: 24935600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
    Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
    J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High level of Sema3C is associated with glioma malignancy.
    Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
    Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
    Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
    Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PinX1 is up-regulated and associated with poor patients' survival in gliomas.
    Bai J; Chen YS; Mei PJ; Liu QH; Du Y; Zheng JN
    Int J Clin Exp Pathol; 2015; 8(6):6952-9. PubMed ID: 26261583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
    Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
    J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of NID2 SNPs with Glioma Risk and Prognosis in the Chinese Population.
    Hao J; Huang C; Zhao W; Zhao L; Hu X; Zhang W; Guo L; Dou X; Jin T; Hu M
    Neuromolecular Med; 2024 Jun; 26(1):27. PubMed ID: 38935278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the MAML2 genetic variants in glioma susceptibility and prognosis.
    Zhang M; Zhao Y; Zhao J; Huang T; Guo X; Ma X; Wu Y
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of four lncRNA polymorphisms (rs2151280, rs7763881, rs1136410, and rs3787016) on glioma risk and prognosis: A case-control study.
    Deng Y; Zhou L; Li N; Wang M; Yao L; Dong S; Zhang M; Yang P; Hao Q; Wu Y; Lyu L; Jin T; Dai Z; Kang H
    Mol Carcinog; 2019 Dec; 58(12):2218-2229. PubMed ID: 31489712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
    Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
    Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
    Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
    J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
    Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
    Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.
    Ding X; Han X; Yuan H; Zhang Y; Gao Y
    Sci Rep; 2020 Mar; 10(1):5140. PubMed ID: 32198386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
    Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
    Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
    Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma.
    Zhang J; Wang P; Ji W; Ding Y; Lu X
    Int J Neurosci; 2017 Mar; 127(3):210-217. PubMed ID: 27050560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
    Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
    J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma.
    Permuth-Wey J; Thompson RC; Burton Nabors L; Olson JJ; Browning JE; Madden MH; Ann Chen Y; Egan KM
    J Neurooncol; 2011 Dec; 105(3):639-46. PubMed ID: 21744077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.
    Guo X; Zhang M; Li Q; Zhao J; Wang B; Wang J; Mao P; Song J
    Am J Clin Oncol; 2020 Jan; 43(1):1-8. PubMed ID: 31513017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
    J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.